-
Industry responds to Biosimilar User Fee Act letter
SILVER SPRING, Md. — The Food and Drug Administration on Friday released the Biosimilar User Fee Act (II) performance goals letter, drawing support from trade groups representing biotechnology companies.Congressional DS Caucus delivers wakeup call to Congress: Sleep is important
WASHINGTON — At the 27th Congressional Dietary Supplement Caucusluncheon briefing, “Counting on Your Sleep: Health and Dietary Supplements,” which took place this week, Michael Grandner, director Sleep and Health Program and assistant professor, psychiatry, medicine and psychology at the University of Arizona College of Medicine, awakened an audience of more than 30 congressional staffers to the health consequences of sleep, addressing the negative outcomes from lack of sleep and the dietary supplements that can help improve sleep.